Source:http://linkedlifedata.com/resource/pubmed/id/18262379
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2008-5-13
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0399-077X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
231-2
|
pubmed:meshHeading |
pubmed-meshheading:18262379-Africa South of the Sahara,
pubmed-meshheading:18262379-Antitubercular Agents,
pubmed-meshheading:18262379-Drug Administration Schedule,
pubmed-meshheading:18262379-Drug Therapy, Combination,
pubmed-meshheading:18262379-Humans,
pubmed-meshheading:18262379-Prevalence,
pubmed-meshheading:18262379-Tuberculosis
|
pubmed:year |
2008
|
pubmed:articleTitle |
Primary resistance to antituberculosis drugs: trends in Cote d'Ivoire from 1995 to 2006.
|
pubmed:publicationType |
Letter
|